Elevated vitreous nitric oxide levels in patients with proliferative diabetic retinopathy

American Journal of Ophthalmology

Volumn 130, Issue 1, 2000, Pages 87-90

  Yilmaz, Gürsel ^a   Esser, Peter ^b   Kociek, Norbert ^b   Aydin, Pinar ^a   Heimann, Klaus ^b  

^a BASKENT UNIVERSITY   (Turkey)

^b UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; FEMALE; HUMAN; HUMAN TISSUE; MALE; PATHOGENESIS; PRIORITY JOURNAL; RETINA DETACHMENT; RETINA MACULA HOLE; SAMPLING; SPECTROPHOTOMETRY; VITRECTOMY; VITREOUS BODY;

ADULT; DIABETES MELLITUS, INSULIN-DEPENDENT; DIABETES MELLITUS, NON-INSULIN-DEPENDENT; DIABETIC RETINOPATHY; FEMALE; HUMAN; MALE; MIDDLE AGE; NITRIC OXIDE; RETINAL DETACHMENT; SUPPORT, NON-U.S. GOV'T; VITRECTOMY; VITREOUS BODY;

EID: 0033825779     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(00)00398-6     Document Type: Article

References (29)

1. Moncada S., Palmer R.M.J., Higgs E.A. Nitric oxide physiology, pathophysiology, and pharmacology . Pharmacol Rev. 43:1991;109-142.
2. Bredt D.S., Snyder S.H. Nitric oxide a physiologic messanger molecule . Ann Rev Biochem. 63:1994;175-195.
3. Nathan C.F. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:1992;3051-3064.
4. Nathan C., Xie Q.W. Nitric oxide synthases roles, tolls, and controls . Cell. 78:1994;915-918.
5. Förstermann U., Kleinert H. Nitric oxide synthase expression and expressional control of the three isoforms . Naunyn-Schmiedeberg's Arch Pharmacol. 352:1995;351-364.
6. Yoshida A., Pozdnyakov N., Dang L., Orselli S.M., Reddy V.N., Sitaramayya A. Nitric oxide synthesis in retinal photoreceptor cells. Vis Neurosci. 12:1995;493-500.
7. Yamamoto R., Bredt D.S., Snyder S.H., Stone R.A. The localization of nitric oxide synthase in the eye and related cranial ganglia. Neuroscience. 54:1993;189-200.
8. Chakravarthy U., Stitt A.W., McNally J., et al. Nitric oxide synthase activity and expression in retinal capillary endothelial cells and pericytes. Curr Eye Res. 14:1995;285-294.
9. Becquet F., Courtois Y., Goureau O. Nitric oxide decreases in vitro phagocytosis of photoreceptor outer segments by bovine retina pigmented epithelial cells. J Cell Physiol. 159:1994;259-262.
10. Dighiero P., Reux I., Hauw J.J., et al. Expression of inducible nitric oxide synthase in cytomegalovirus-infected glial cells of retinas from AIDS patients. Neurosci Lett. 166:1994;31-34.
11. Goureau O., Hicks D., Courtois Y., Kozak Y. Induction and regulation of nitric oxide synthase in retinal Müller glial cells. J Neurochem. 63:1994;310-317.
12. Goureau O., Bellot J., Thillage B., Courtois Y., De Kozak Y. Increased nitric oxide production in endotoxin-induced uveitis. J Immunol. 154:1995;6518-6523.
13. Jacquemin E., Kozak Y., Thillaye B., Courtois Y., Goureau O. Expression of inducible nitric oxide synthase in the eye from endotoxin-induced uveitic rats. Invest Ophthalmol Vis Sci. 37:1996;1187-1196.
14. Tilton R.G., Chang K., Corbett J.A., et al. Endotoxin-induced uveitis in the rat is attenuated by inhibition of nitric oxide production. Invest Ophthalmol Vis Sci. 35:1994;3278-3288.
15. Goldstein I.M., Ostwald P., Roth S. Nitric oxide a review of its role in retinal function and disease . Vision Res. 36:1996;2979-2994.
16. Becquet F., Courtois Y., Goureau O. Nitric oxide in the eye multifaceted roles and diverse outcomes . Surv Ophthalmol. 42:1997;71-82.
17. Merimee T.J. Diabetic retinopathy. A synthesis of perspectives. N Engl J Med. 322:1990;978-983.
18. Abu el Asrar A.M., Maimone D., Morse P.H., Gregory S., Reder A.T. Cytokines in the vitreous of patients with proliferative diabetic retinopathy. Am J Ophthalmol. 114:1992;731-736.
19. Franks W.A., Limb G.A., Stanford M.R., et al. Cytokines in human intraocular inflammation. Curr Eye Res. 11:(suppl):1992;187-191.
20. Goureau O., Hicks D., Courtois Y. Human retina pigment epithelial cells produce nitric oxide in response to cytokines. Biochem Biophys Res Comm. 198:1994;120-126.
21. Goureau O., Lepoivre M., Becquet F., Courtois Y. Differential regulation of inducible nitric oxide synthase by fibroblast growth factors and transforming growth factor beta. Proc Natl Acad Sci USA. 90:1993;4276-4280.
22. Goureau O., Lepoivre M., Courtois Y. Lipopolysaccharide and cytokines induce a macrophage-type of nitric oxide synthase in bovine retina pigmented epithelial cells. Biochem Biophys Res Comm. 186:1992;854-859.
23. do Carmo A., Lopes C., Santos M., Proença R., Cunha-Vaz J., Carvalho A.P. Nitric oxide synthase activity and L-arginine metabolism in the retinas from streptozotocin-induced diabetic rats. Gen Pharmac. 30:1998;319-324.
24. Green R., Wagner D., Glagowski J., Skipper P.L., Wishnok J., Tannenbaum S.R. Analysis of nitrate, nitrite and (15N) nitrate in biological fluids. Anal Biochem. 126:1982;131-138.
25. Hammes H.P., Martin S., Federlin K., Geisen K., Brownlee M. Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. Proc Natl Acad Sci USA. 88:1991;11555-11558.
26. Misko P.T., Moore W.M., Kasten T.P., et al. Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur J Pharmacol. 233:1993;119-125.
27. Tilton R.G., Chang K., Hasan K.S., et al. Prevention of diabetic vascular dysfunction by guanidines. Diabetes. 42:1993;221-232.
28. Corbett J.A., Tilton R.G., Chang K., et al. Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes. 41:1992;552-556.
29. Frank R.N. Diabetic retinopathy. Prog Retin Eye Res. 14:1995;361-393.